Hi Monti
Yes, it’s more about the goodwill.
Nobody knows who is on active and who is on placebo, so any sense of how the treatment is performing is, at best, an overall sense.
The trial design guarantees that those on Placebo will get Avicursen after getting the Placebo for 6 months..
It’s more to do with people to enroll in the trial
Also imo the 9 month data will be better ..
All those after the 12 month sturdy will carry on with Avicursen if desired…
Ann: Quarterly Activities Report and Appendix 4C, page-5
Add to My Watchlist
What is My Watchlist?
